Our mission is simple : To transform the treatment of degenerative diseases by harnessing the body’s natural healing process— making it affordable and available to everyone.

Founded in Belgium in 2019, Conveyxo combines breakthrough science with smart manufacturing to create therapies that do more than ease symptoms—they aim to reverse disease progression. We harness the power of tiny stem cell messengers called exosomes, natural carriers of anti-inflammatory and regenerative signals, making them the next generation of cell-free therapies. We enhance their properties by combining additional therapeutic payloads – like RNA – to deliver best-in-class treatments designed to restore health at its source.

We’re tackling the root causes of chronic inflammation and tissues degeneration, starting with osteoarthritis, a condition that affects millions worldwide. We’ve already seen promising results in preclinical studies and plan to start clinical trials by early 2027. Beyond osteoarthritis, we’re working on solutions for skin conditions like eczema, as well as gut, kidney, and brain health.

Our technology makes these treatments scalable and cost-effective, so they can reach patients everywhere—not just a privileged few.

At Conveyxo, innovation meets impact.

Together, with breakthrough RNA-enhanced exosomes-based therapies, we can build a future where better health is within everyone’s reach.